Aim Immunotech Inc (NY: AIM )
0.2149
+0.0079
(+3.82%)
Streaming Delayed Price
Updated: 11:52 AM EST, Dec 9, 2024
Add to My Watchlist
Headline News about Aim Immunotech IncVia Benzinga
AIM ImmunoTech Receives Positive FDA Response For Ampligen Trial In PCCD Patients
September 21, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|